Isolated Limb Perfusion With Tumor Necrosis Factor α and Melphalan for Locally Advanced Soft Tissue Sarcoma: The Value of Adjuvant Radiotherapy

被引:0
|
作者
Katja M. J. Thijssens
Robert J. van Ginkel
Elisabeth Pras
Albert J. H. Suurmeijer
Harald J. Hoekstra
机构
[1] University Medical Center Groningen,Department of Surgical Oncology
[2] University Medical Center Groningen,Department of Radiation Oncology
[3] University Medical Center Groningen,Department of Pathology
来源
Annals of Surgical Oncology | 2006年 / 13卷
关键词
Sarcoma; Isolated limb perfusion; Radiotherapy; Tumor necrosis factor; Melphalan; Long-term results.;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:518 / 524
页数:6
相关论文
共 50 条
  • [21] Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas
    Farre Alegre, Jose
    Duarte, Maritza
    Sureda Gonzalez, Manuel
    Bretcha Boix, Pere
    Dussan, Carlos
    Ballester, Antonio
    Crespo, Aurora
    Brugarolas Masllorens, Antonio
    CIRUGIA ESPANOLA, 2012, 90 (02): : 114 - 120
  • [22] Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors
    Vrouenraets, BC
    Keus, RB
    Nieweg, OE
    Kroon, BB
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 65 (02) : 88 - 94
  • [23] Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-α and melphalan for limb-threatening soft tissue sarcoma
    Grunhagen, DJ
    de Wilt, JHW
    Graveland, WJ
    Verhoef, C
    van Geel, AN
    Eggermont, AMM
    CANCER, 2006, 106 (08) : 1776 - 1784
  • [24] Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma
    Thijssens, Katja M. J.
    Hoekstra-Weebers, Josette E. H. M.
    van Ginkel, Robert J.
    Hoekstra, Harald J.
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (06) : 864 - 871
  • [25] Quality of Life After Hyperthermic Isolated Limb Perfusion for Locally Advanced Extremity Soft Tissue Sarcoma
    Katja M. J. Thijssens
    Josette E. H. M. Hoekstra-Weebers
    Robert J. van Ginkel
    Harald J. Hoekstra
    Annals of Surgical Oncology, 2006, 13 : 864 - 871
  • [26] Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Stewart-Treves lymphangiosarcoma
    T. E. Lans
    J. H. W. de Wilt
    A. N. van Geel
    A. M. M. Eggermont
    Annals of Surgical Oncology, 2002, 9 : 1004 - 1009
  • [27] Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
    Nachmany, I.
    Subhi, A.
    Meller, I.
    Gutman, M.
    Lahat, G.
    Merimsky, O.
    Klausner, J. M.
    EJSO, 2009, 35 (02): : 209 - 214
  • [28] Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience
    Rastrelli, Marco
    Campana, Luca Giovanni
    Valpione, Sara
    Tropea, Saveria
    Zanon, Antonio
    Rossi, Carlo Riccardo
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (02) : 165 - 172
  • [29] Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan
    Santinami, M
    Deraco, M
    Azzarelli, A
    Cascinelli, F
    Chiti, A
    Costagli, V
    Inglese, MG
    Manzi, R
    Quagliolo, V
    Rebuffoni, G
    Santoro, N
    Vaglini, M
    TUMORI, 1996, 82 (06) : 579 - 584
  • [30] Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable Stewart-Treves lymphangiosarcoma
    Lans, TE
    de Wilt, JHW
    van Geel, AN
    Eggermont, AMM
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) : 1004 - 1009